Allelic expression and interleukin-2 polymorphisms in multiple sclerosis

J Neuroimmunol. 2001 Sep 3;119(1):101-5. doi: 10.1016/s0165-5728(01)00354-x.

Abstract

We have investigated the association of two single nucleotide polymorphisms (SNPs) at positions -384 and 114 in the human interleukin-2 (hIL-2) with multiple sclerosis (MS). For two of the -384 genotypes (G/T, T/T), we observed an association with the susceptibility to secondary progressive (SP) course of MS (P=0.005 and P=0.013, respectively). Expression level differences of the IL-2 alleles (between one- and three-fold) were not attributable to the -384 promoter polymorphism. These data indicate for the first time the relevance of the il-2 gene locus in human MS and its possible involvement in other autoimmune diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age of Onset
  • Alleles*
  • Gene Frequency
  • Humans
  • Interleukin-2 / genetics*
  • Multiple Sclerosis, Chronic Progressive / epidemiology
  • Multiple Sclerosis, Chronic Progressive / genetics*
  • Multiple Sclerosis, Relapsing-Remitting / epidemiology
  • Multiple Sclerosis, Relapsing-Remitting / genetics*
  • Polymorphism, Genetic*
  • Reference Values

Substances

  • Interleukin-2